Several indications and molecules were approved in July by FDA including the following: Asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component...
KEYTRUDA
The FDA approved several medications in May including the following: Infigratinib, a kinase inhibitor for adults with previously treated, unresectable...
In November, three (3) indications/molecules were approved by FDA: Sonalleve MR-HIFU system for the treatment of osteoid osteoma in the...
